Shlomi Schwartzblat

Shlomi Schwartzblat has a long history of work experience in various fields. In 2009, they were an Investor, Director, and Board of Directors for Bonfix, a company developing a minimally invasive hallux valgus correction device. In 2010, they were an Investor, Director, and Board of Directors for OCON Medical, a company developing unique women's health implants and pharmaceuticals based on SMA technology. In 2011, they were an Investor, Director, and Board of Directors for EYEYON MEDICAL. In 2012, they were an Investor, Director, and Board of Directors for Raziel therapeutics and a Director and Board of Directors for Laryngoport. In 2013, they were an Investor, Director, and Board of Directors for Xsight Systems. In 2016, they were the CEO and Founder of Gavriel Ventures, a company focused on investments, business development and management services in various fields. In 2018, they were a Partner for LATAM Business Development Group, a business consulting and development firm specializing in the Latin American markets. In 2019, they were a Mentor for Jerusalem College of Engineering. In 2020, they were a Co-Founder for Front BioPharma.

Shlomi Schwartzblat holds a Master of Business Administration - MBA from Tel Aviv University and a Master of Science - MSc. Engineering and Information systems from Ben-Gurion University of the Negev.